In this session from the SOHO Insider Community Oncology series, Hans Lee, MD, director of Multiple Myeloma Research at Sarah Cannon Research Institute, discusses strategies to increase United States patient representation in global clinical trials.
Host Dr. Loretta Nastoupil discusses with Dr. Lee the operational, structural, and financial barriers to trial accrual, as well as practical approaches to bring complex studies, including bispecific antibodies and early-phase regimens, into community oncology settings.
Leave feedback about this